Papaverine Hydrochloride

Basic Information

Item Value
DrugBank ID DB01113
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 82

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 ischemic disease KG + DL
2 intracranial arteriosclerosis KG + DL
3 non-inflammatory vasculopathy KG + DL
4 vascular ectasia KG + DL
5 fibrocartilaginous embolism KG + DL
6 venous thromboembolism KG + DL
7 vascular insufficiency disorder KG + DL
8 angiodysplasia KG + DL
9 Raynaud disease KG + DL
10 Monckeberg arteriosclerosis KG + DL
11 congenital renal artery stenosis KG + DL
12 headache disorder KG + DL
13 benign prostatic hyperplasia (disease) KG + DL
14 kyphoscoliotic heart disease KG + DL
15 pulmonary hypertension KG + DL
16 trigeminal autonomic cephalalgia KG + DL
17 thrombotic disease KG + DL
18 spinal cord ischemia KG + DL
19 Prinzmetal angina KG + DL
20 priapism KG + DL
21 cor pulmonale KG + DL
22 vein disease KG + DL
23 May-Thurner syndrome KG + DL
24 livedo reticularis KG + DL
25 lateral sinus thrombosis KG + DL
26 cavernous sinus thrombosis KG + DL
27 stroke disorder KG + DL
28 common cold KG + DL
29 nasal cavity disease KG + DL
30 hereditary arterial and articular multiple calcification syndrome KG + DL
31 peripheral ischemia KG + DL
32 mesenteric vascular occlusion KG + DL
33 erythromelalgia KG + DL
34 arterial calcification of infancy KG + DL
35 primary hereditary glaucoma KG + DL
36 massive neonatal aspiration syndrome KG + DL
37 papillary conjunctivitis KG + DL
38 hantavirus infectious disease KG + DL
39 meconium aspiration syndrome KG + DL
40 acute laryngopharyngitis KG + DL
41 lung disease KG + DL
42 respiratory syncytial virus bronchiolitis KG + DL
43 allergic asthma KG + DL
44 pharyngitis KG + DL
45 open-angle glaucoma KG + DL
46 allergic urticaria KG + DL
47 atrial fibrillation (disease) KG + DL
48 cerebrovascular disorder KG + DL
49 intrinsic asthma KG + DL
50 Ambras type hypertrichosis universalis congenita KG + DL

(Showing top 50 of 82 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.